These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 26796821)

  • 1. Avoiding Adverse Events Secondary to Opioid-Induced Respiratory Depression: Implications for Nurse Executives and Patient Safety.
    Jungquist CR; Correll DJ; Fleisher LA; Gross J; Gupta R; Pasero C; Stoelting R; Polomano R
    J Nurs Adm; 2016 Feb; 46(2):87-94. PubMed ID: 26796821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Society for Pain Management Nursing guidelines on monitoring for opioid-induced sedation and respiratory depression.
    Jarzyna D; Jungquist CR; Pasero C; Willens JS; Nisbet A; Oakes L; Dempsey SJ; Santangelo D; Polomano RC
    Pain Manag Nurs; 2011 Sep; 12(3):118-145.e10. PubMed ID: 21893302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A national survey of American Pediatric Anesthesiologists: patient-controlled analgesia and other intravenous opioid therapies in pediatric acute pain management.
    Nelson KL; Yaster M; Kost-Byerly S; Monitto CL
    Anesth Analg; 2010 Mar; 110(3):754-60. PubMed ID: 20185654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Instituting best practice for monitoring for opioid-induced advancing sedation in hospitalized patients.
    Jungquist CR; Pasero C; Tripoli NM; Gorodetsky R; Metersky M; Polomano RC
    Worldviews Evid Based Nurs; 2014 Dec; 11(6):350-60. PubMed ID: 25252100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk predictors of opioid-induced critical respiratory events in children: naloxone use as a quality measure of opioid safety.
    Chidambaran V; Olbrecht V; Hossain M; Sadhasivam S; Rose J; Meyer MJ
    Pain Med; 2014 Dec; 15(12):2139-49. PubMed ID: 25319840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ASPMN survey--nurses' practice patterns related to monitoring and preventing respiratory depression.
    Willens JS; Jungquist CR; Cohen A; Polomano R
    Pain Manag Nurs; 2013 Mar; 14(1):60-5. PubMed ID: 23452528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring for opioid-induced advancing sedation and respiratory depression: ASPMN membership survey of current practice.
    Jungquist CR; Willens JS; Dunwoody DR; Klingman KJ; Polomano RC
    Pain Manag Nurs; 2014 Sep; 15(3):682-93. PubMed ID: 24657237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of and risk factors for adverse events in children receiving patient-controlled analgesia by proxy or patient-controlled analgesia after surgery.
    Voepel-Lewis T; Marinkovic A; Kostrzewa A; Tait AR; Malviya S
    Anesth Analg; 2008 Jul; 107(1):70-5. PubMed ID: 18635469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addressing Safe Opioid Monitoring Practices Using an Interprofessional Approach.
    Durham ML; Egan A; Jankiewicz A; Murphy MP; Nedved P; Luvich R; Goh A; Fogg L
    J Nurs Adm; 2017 Nov; 47(11):537-544. PubMed ID: 29045356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The frequency and timing of respiratory depression in 1524 postoperative patients treated with systemic or neuraxial morphine.
    Shapiro A; Zohar E; Zaslansky R; Hoppenstein D; Shabat S; Fredman B
    J Clin Anesth; 2005 Nov; 17(7):537-42. PubMed ID: 16297754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A risk stratification algorithm using non-invasive respiratory volume monitoring to improve safety when using post-operative opioids in the PACU.
    Voscopoulos C; Theos K; Tillmann Hein HA; George E
    J Clin Monit Comput; 2017 Apr; 31(2):417-426. PubMed ID: 26894592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous noninvasive respiratory volume monitoring for the identification of patients at risk for opioid-induced respiratory depression and obstructive breathing patterns.
    Voscopoulos CJ; MacNabb CM; Freeman J; Galvagno SM; Ladd D; George E
    J Trauma Acute Care Surg; 2014 Sep; 77(3 Suppl 2):S208-15. PubMed ID: 25159358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring Hospitalized Adult Patients for Opioid-Induced Sedation and Respiratory Depression.
    Jungquist CR; Smith K; Nicely KL; Polomano RC
    Am J Nurs; 2017 Mar; 117(3 Suppl 1):S27-S35. PubMed ID: 28212147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacovigilance: a review of opioid-induced respiratory depression in chronic pain patients.
    Dahan A; Overdyk F; Smith T; Aarts L; Niesters M
    Pain Physician; 2013; 16(2):E85-94. PubMed ID: 23511694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid-induced respiratory depression in the acute care setting: a compendium of case reports.
    Overdyk F; Dahan A; Roozekrans M; van der Schrier R; Aarts L; Niesters M
    Pain Manag; 2014 Jul; 4(4):317-25. PubMed ID: 25300390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Findings of a Naloxone Database and its Utilization to Improve Safety and Education in a Tertiary Care Medical Center.
    Rosenfeld DM; Betcher JA; Shah RA; Chang YH; Cheng MR; Cubillo EI; Griffin JM; Trentman TL
    Pain Pract; 2016 Mar; 16(3):327-33. PubMed ID: 25564757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The London low emission zone baseline study.
    Kelly F; Armstrong B; Atkinson R; Anderson HR; Barratt B; Beevers S; Cook D; Green D; Derwent D; Mudway I; Wilkinson P;
    Res Rep Health Eff Inst; 2011 Nov; (163):3-79. PubMed ID: 22315924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a higher risk of respiratory depression in opioid-naïve palliative care patients during symptomatic therapy of dyspnea with strong opioids?
    Clemens KE; Quednau I; Klaschik E
    J Palliat Med; 2008 Mar; 11(2):204-16. PubMed ID: 18333735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for opioid-induced excessive respiratory depression.
    Jungquist CR; Karan S; Perlis ML
    Pain Manag Nurs; 2011 Sep; 12(3):180-7. PubMed ID: 21893307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.